News & Events

2008

  • June 2008 – Milagen is awarded Phase II Small Business Innovation Research Grant (SBIR) sponsored by the National Cancer Institute (NCI) on “Serum-Based Assays for Pancreatic Cancer Detection”
  • April 2008 – 99th Annual Meeting, American Association for Cancer Research, April 14- 18, San Diego, CA, “Sandwich ELISA serum-based immunoassay for lung cancer detection” C. Chavany, J. Paniagua, S.C. Chen, J.Dea1, J. Sodhi1, K. Hung1, C-Z-Yu1, R.P.C. Valle, M. Jendoubi, 1AbNovel Corporation, Poster Presentation, Dr. Christine Chavany
  • April 2008 – 99th Annual Meeting, American Association for Cancer Research, April 14-18, San Diego, CA, “Sandwich ELISA serum-based immunoassay for colon cancer detection” C. Chavany, J. Paniagua, S.C. Chen, J.Dea1, J. Sodhi1, K. Hung1, C-Z-Yu1, R.P.C. Valle, M. Guevara2, R. Hernandez-Gonzalez2, M. Jendoubi, 1AbNovel Corporation, 2Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Poster Presentation, Dr. Moncef Jendoubi
  • February 2008 - ASCO GenitoUrinary Symposium, February 14-16, San Francisco, CA, “Monoclonal antibodies and serum-based immunoassay for prostate cancer “C. Chavany, J. Paniagua, S.C. Chen, J.Dea1, J. Sodhi1, K. Hung1, C-Z-Yu1, R.P.C. Valle, M. Jendoubi, 1AbNovel Corporation, Poster Presentation, Dr. Rosaura P.C. Valle

2007

  • April 2007 – 98th Annual Meeting, American Association for Cancer Research, April 14- 18, Los Angeles, CA, “Monoclonal antibody serum-based immunoassay for colon cancer detection” C. Chavany, S.C. Chen, J. Paniagua, R.P.C. Valle, M. Guevara1, R. Hernandez-Gonzalez1, M. Jendoubi, 1Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Poster Presentation, Dr. Moncef Jendoubi
  • April 2007 – 98th Annual Meeting, American Association for Cancer Research, April 14-18, Los Angeles, CA, “Monoclonal antibody serum-based immunoassay for lung cancer early detection” C. Chavany, S.C. Chen, J. Paniagua, R.P.C. Valle, M. Guevara1, R. Hernandez-Gonzalez1, M. Jendoubi, 1Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Poster Presentaiton, Dr. Christine Chavany

2006

  • December 2006 - AACR Innovations in Prostate Cancer Research, December 6-9, San Francisco, CA, ”Monoclonal antibody serum-based immunoassay for prostate cancer ealry detection”, C. Chavany, S. Chen, J. Paniagua, R. P.C. Valle, M. Guevara1, R. Hernandez-Gonzalez1, M Jendoubi 1Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Poster Presentation, Dr. Rosaura P.C. Valle
  • September 2006 - Milagen is awarded Phase I Small Business Research Grant (SBIR) sponsored by the National Cancer Institute (NCI) on “Serum-Based Assays for Pancreatic Cancer Detection”
  • April 2006 – 97th Annual Meeting, American Association for Cancer Research, April 1-5, Washington, DC, “Development of a serum-based immunoassay for the early detection of prostate cancer” C. Chavany, S.C. Chen, S.R. Schramm, R.P.C. Valle, G. Malik*, O.J. Semmes, M. Jendoubi * Eastern Virginia Medical School, Poster Presentation, Dr. Christine Chavany
  • April 2006 - 97th Annual Meeting, American Association for Cancer Research, April 1-5, Washington, DC, “Biomarkers and serum-based immunoassay for the early detection of localized colon cancer” C. Chavany, S.C. Chen, S.R. Schramm, R.P.C. Valle, M. Jendoubi, Poster Presentation, Dr. Moncef Jendoubi
  • February 2006 - Milagen to present at ASCO Prostate Cancer Symposium, February 24-26, 2006, San Francisco, CA “Development of a serum-based immunoassay for the detection of benign hyperplasia of the prostate” C. Chavany, S. Chen, S. Schramm, R.P.C. Valle, J.O. Semmes*, M. Jendoubi, * Eastern Virginia Medical School,
  • February 2006 - Milagen to present at ASCO Prostate Cancer Symposium, February 24-26, 2006, San Francisco, CA, “Development of a serum-based immunoassay for the early detection of prostate cancer” M. Jendoubi, C. Chavany, S. Chen, S. Schramm, J.O. Semmes*, R.P.C. Valle * Eastern Virginia Medical School
  • January 2006 – Milagen to present at ASCO Gastrointestinal Cancers Symposium, January 26-28, 2006, San Francisco, CA, “ Development of a serum-based immunoassay for the early detection of localized colon cancer” C. Chavany, S. Chen, S. Schramm, R.P.C. Valle, M. Jendoubi
  • January 2006 – Milagen to present at ASCO Gastrointestinal Cancers Symposium, January 26-28, 2006, San Francisco, CA, “Validation of tissue specific biomarkers for the early detection of localized colon cancer” C. Chavany, S. Chen, S. Schramm, R.P.C. Valle, M. Jendoubi

2005

  • September 2005- Milagen and AbNovel Corporation (www.abnovel.com) an emerging reagent company have signed a collaboration agreement for the production of monoclonal antibodies to selected biomarkers for the development of immunodiagnostic products. Dr. Jendoubi said “…we are very pleased to collaborate with AbNovel Corporation. This is the last piece of a number of milestones on our agenda toward the manufacturing of our immunodiagnostic products.”
  • September 2005 - Milagen is awarded Phase I Small Business Research Grant (SBIR) sponsored by the National Institute for Digestive, Diabetes and Kidney Diseases (NIDDK) on “Serum Biomarkers for Early Detection of Type 2 Diabetes”
  • September 2005 – Milagen is awarded Phase II Small Business Innovation Research Contract (SBIR) sponsored by the National Cancer Institute (NCI) for the “Development of Biomarkers for Prostate Cancer Disease Management”
  • April 2005 – 96th Annual Meeting, American Association for Cancer Research, April 15-20, 2005, Anaheim, CA, “Development of a Panel of Serum Biomarkers for Early Detection of Lung Cancer” C. Chavany, S. Chen, R.P.C. Valle, S. Schramm, A. Greenberg*, D. Seligson+, L. Goodlick+, B. Crawford*, M. Zervos*, E. Eylers*, D. Chia+, W.N. Rom*, M. Jendoubi, *NYU School of Medicine, +UCLA Immunogenetics Research Center, Poster Presentation, Dr. Christine Chavany
  • April 2005 – 96th Annual Meeting, American Association for Cancer Research, April 15-20, 2005, Anaheim, CA, “Development of a Serum Based Diagnostic Immuno-diagnostic Assay for the Early Detection of Colon Cancer” C. Chavany, S. Chen, R.P.C. Valle, S. Schramm, M. Jendoubi, Poster Presentation, Dr. Moncef Jendoubi
  • April 2005 – 96th Annual Meeting, American Association for Cancer Research, April 15-20, 2005, Anaheim, CA, “Milagen #44 Protein Expression is a Potential Early Detection Biomarker of Lung Cancer” V. Mah+, D. Seligson+, C. Chavany, S. Chen, R.P.C. Valle, M. Jendoubi, L. Goodlick+, D. Chia+, +UCLA Immunogenetics Research Center, Abstract Publication, Poster Presentation, V. Mah

2004

  • September 2004 - Early Detection Research Network, Lung Cancer Biomarker Workshop, September 18-20, 2004, University of Colorado, Denver, CO, “Validation Study on a Biomarker Panel for Early Lung Cancer Detection in Serum” Invited Speaker, Dr. Moncef Jendoubi. In Collaboration with the NCI (EDRN) Milagen has conducted a blind experiment and has successfully validated its immunodiagnostic biomarkers for the early detection of lung cancer in serum
  • September 2004 – Early Detection Research Network, GU Collaborative Group Meeting, September 13-14, 2004, Houston TX, Invited Speaker, Dr. Moncef Jendoubi
  • July 2004 – AACC Annual Meeting, American Association of Clinical Chemistry, July 25-29, 2004, Los Angeles, CA, Dr. Moncef Jendoubi
  • July 2004 – Milagen is awarded two-year grant funding through Associate Membership with the Early Detection Research Network for “ Antibody early detection of prostate cancer biomarkers”
  • June 2004 – 40th Annual ASCO Meeting, American Association of Clinical Oncology, June 5-8, 2004, New Orleans, LO, “Candidate Secreted Biomarkers for Prostate Cancer Detection” C. Chavany, S. Chen, S. Schramm, R.P.C. Valle, J.O. Semmes*, M. Jendoubi, * Eastern Virginia Medical School, Poster Presentation, Dr. Moncef Jendoubi
  • June 2004 – Early Detection Research Network, EDRN Associate Member Meeting, June 12-14, 2004, Bethesda, MD, “Antibody-Based Early Detection of Prostate Cancer Biomarkers” C. Chavany, S. Chen, S. Schramm, R.P.C. Valle, G. Malik*, J.O. Semmes*, M. Jendoubi, * Eastern Virginia Medical School, Roundtable Discussion Panelist, Dr. Moncef Jendoubi
  • May 15, 2004 – Milagen exceeds set milestones in the Final Report of NCI Phase I Small Business Innovation Research Contract (SBIR) on “High-Throughput Protein Profiling in Mouse Models of Cancer”
  • March 2004 – 95th Annual Meeting, American Association for Cancer Research, March 27-31, 2004, Orlando, FL, “Candidate Secreted Biomarkers for the Early Detection of Lung Cancer” C. Chavany, S. Schramm, R.P.C. Valle, M. Jendoubi, A. Greenberg*, W.N. Rom*, *NYU School of Medicine, Poster Presentation, Dr. Christine Chavany
  • March 2004 – 60th Annual Meeting, American Academy of Allergy, Asthma, & Immunology, March 19-23, 2004, San Francisco, CA, “Candidate Serum Biomarkers for Predictive Medicine and Disease Management of Asthma” J. Just*, C. Chavany, K. Yamaguchi, S. Chen, S. Schramm, F. Sahraoui*, A. Grimfeld*, M. Jendoubi, * Hospital Armand Trousseau, Paris, France, Poster Presentation, Dr. Christine Chavany
  • March 2004 – Fred Hutchinson Cancer Research Center, March 18, 2004, Seattle, WA, “Discovery and Validation of Biomarkers and their Utility Application for Diagnostic and Disease Management in Cancer” Invited Speaker, Dr. Moncef Jendoubi
  • February 2004 – Scientific and Technological Advances in Cancer Research, IBC LifeSciences, February 11-13, 2004, Reston, VA, “ Discovery and Validation of Molecular Signatures and their Utility Application for Diagnostic and Disease Management in Cancer” Invited Speaker, Dr. Moncef Jendoubi
  • February 6, 2004 – Milagen is awarded Associate Membership with the Early Detection Research Network
  • February 2004 – 9th EDRN Steering Committee Meeting, Early Detection Research Network, February 2-4, 2004, University of Texas Southwestern Medical Center, Dallas, TX, “Antibody Array for Cancer Detection” Guest Speaker, Dr. Moncef Jendoubi

2003

  • December 2003 – Publication with the Early Detection Research Network, “Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancer”, W.E. Grizzle, B.L. Adam, W.L. Bigbee, T.P. Conrads, C. Carroll, Z. Feng, M. Jendoubi, et al. (2003-2004), Dis Marker 19(4-5):185-195
  • October 2003 –AACR Frontiers in Cancer Prevention Research, October 26-30, 2003, Phoenix, AZ, “Candidate Secreted Biomarkers in Plasma for the Early Detection of Stage I Lung Cancer” C. Chavany, S. Chen, K. Yamaguchi, S. Schramm, M. Jendoubi, S. Zafar*, A. Greenberg*, B. Crawford*, M. Zervos*, W.N. Rom*, * NYU School of Medicine, Poster Presentation, Dr. Christine Chavany
  • October 2003 –AACR Frontiers in Cancer Prevention Research, October 26-30, 2003, Phoenix, AZ, “Metastatic versus Non-metastatic Serum Markers in Melanoma” C. Chavany, S. Chen, K. Yamaguchi, S. Schramm, M. Jendoubi, L. Shaik*, M. Kashani-Sabet*, *UCSF Melanoma Center, Poster Presentation, Dr. Moncef Jendoubi
  • October 2003 –AACR Frontiers in Cancer Prevention Research, October 26-30, 2003, Phoenix, AZ, “Identification of Distinct Secreted Biomarkers in Serum for Ovarian Cancer Stages I-IV” S. Chen, C. Chavany, K. Yamaguchi, S. Schramm, M. Jendoubi, Poster Presentation, Steven Chen
  • September 2003 – Milagen is awarded Phase I Small Business Innovation Research Contract (SBIR) sponsored by the National Cancer Institute (NCI) on “High-Throughput Protein Profiling in Mouse Models of Cancer”
  • July 2003 - 94th Annual Meeting, American Association for Cancer Research, July 11-14, 2003, Washington, DC, “Antibody-based Approach to Biomarker Discovery: Identification of Stage Specific Antibodies and Protein Targets in Breast Cancer” C. Chavany, M. Jendoubi, Poster Presentation, Dr. Christine Chavany
  • March 2003 - Proteomics: Technologies and Applications, Keystone Symposium 2003, March 25-30, Keystone, CO, “Large-scale Functional Approach of Proteins in Human Diseases” C. Chavany, M. Jendoubi
  • March 2003 - Molecular Targets for Cancer therapy, Keystone Symposium 2003, March 19-24, 2003, Banff, Alberta, Canada, “Unique Antibody-based Approach to Target Discovery in Cancer: Application to the Identification of Protein Targets in Breast Cancer” C. Chavany, M. Jendoubi, Poster Presentation, Dr. Moncef Jendoubi
  • March 2003 – “Antibody-based technologies for target discovery” R.P.C. Valle, M. Jendoubi, Current Opinion in Drug Discovery & Development, 6(2):197-203
  • February 2003 – Technological Advances in Cancer Research, IBC Lifesciences, February 10-12, 2003, Bethesda, MD, “Multiplexed Antibody-Base Approach for Target Discovery and Diagnostic Applications in Cancer,” Invited Speaker, Dr. Moncef Jendoubi
  • February 2003 – Antibody Therapeutics in Cancer, Keystone Symposium 2003, February 4-9, 2003, Banff, Alberta, Canada “AntibiomixTM: A Unique Antibody-Based Approach for Target Discovery” C. Chavany, S. Chen, Y. Xu, E.Q. Fernandez, R.P.C. Valle, M. Jendoubi, Poster Presentation, Dr. Christine Chavany
  • January 2003 - "New approaches for biomarker discovery in lung cancer" R.P.C. Valle, C. Chavany, T.A. Zhukov, M. Jendoubi, Expert Review of Molecular Diagnostics 3(1):55-67

2002

  • December 2002 - Antibody Engineering, IBC Lifesciences, December 1-4, 2002, San Diego, CA, “Antibiomix™ for Disease Phenotype” Invited Speaker, Dr. Moncef Jendoubi
  • October 2002 - Chips to Hits 2002, IBC Lifesciences, October 27-31, 2002, Philadelphia, PA, “Antibody-Based Target Discovery Via Matrix Protein Arrays” Invited Speaker, Dr. Moncef Jendoubi
  • October 2002 - SELDI-Prostate Cancer – PCPT Meeting, Early Detection Research Network, The University of Texas Health Science Center at San Antonio, TX, Invited Guest, Dr. Moncef Jendoubi
  • September 30, 2002 - National Institutes of Health, Bethesda, MD, “From Gene Products to Disease Phenotype: Antibody Chips for Predictive Medicine in Cancer” Invited Speaker, Dr. Moncef Jendoubi. Seminar to be webcasted between 2:00-4:00 p.m. ET linkwebcast
  • September 2002 - EDRN Steering Committee Meeting, Public Private Partnership Workshop, Early Detection Research Network, September 3-6, 2002, University of Michigan, Ann Arbor, MI, Invited Guest, Dr. Moncef Jendoubi
  • August 26, 2002 - "Aspiring to pharmaceuticals, Milagen hopes to sell antibodies arrays in the short run" John S. McNeil, ProteoMonitor, Vol. 2, No. 33, pp 3, a view at Milagen from the global newsweekly of proteomic technology
  • August 2002 - Cancer Genetics & Tumor Suppressor Genes, Cold Spring Harbor Laboratory, August 14-18, 2002, New York, NY, “Breaking the Bottleneck of Genomics and Proteomics” Invited Speaker, Dr. Moncef Jendoubi
  • August 2002 - Drug Discovery Technology 2002, IBC LifeSciences, August 5-9, 2002, Boston, MA, C. Chavany, J-F. Martini, R.P.C. Valle, M. Jendoubi, "Antibiomix(TM): Antibody-based Target Discovery and Validation for Diagnostics and Therapeutics" Poster Presentation, Dr. Rosaura Valle
  • July/August 2002 (PDF file) - Company Profile "Milagen, Inc.: Revolutionizing predictive medicine and therapeutics" R.P.C. Valle, American Genomic/Proteomic Technology, pp 20-21
  • June 2002 - Intellectual Property/Technology Transfer Summit, Strategic Research Institute, July 18-19, 2002, Philadelphia, Panel on Proteomics, Invited Speaker, Dr. Rosaura Valle
  • May 14, 2002 - "The matching game" Randall C. Willis, Modern Drug Discovery, May 2002, Vol. 5, No. 5, pp 26-28, 30, 32-33, a review of Milagen and various protein-based chip companies, and their application in proteomics and diagnostics
  • May 14, 2002 - "A binding proposition," Randall C. Willis, Modern Drug Discovery, May 2002, Vol. 5, No. 5, pp 47-49, more on Milagen and antibody array companies
  • May 14, 2002 (PDF file) - "Linking proteins to disease" R.P.C.Valle, C. Chavany, R. Hernandez-Gonzalez, M. Jendoubi, Current Drug Discovery, May 2002, pp 35-39, or how antibodies are used at Milagen to correlate gene products to disease phenotype
  • May 2002 - 4th Annual C21 Ventures - The future of BioVenture Investing, Techvision, May 6-8, 2002, San Diego, CA, Invited Speaker, Dr. Moncef Jendoubi
  • April 2002 - 93rd Annual Meeting, American Association for Cancer Research, April 6-10, 2002, San Francisco, CA, “AntibiomixTM: Antibody-based Target Discovery and Validation for Cancer by Matrix Protein Array” C. Chavany, J-F. Martini, R.P.C. Valle, M. Jendoubi, Poster Presentation, Dr. Christine Chavany
  • March 28, 2002 - Milagen's AntibiomixTM Revolutionizes Antibody Chips for Predictive Medicine Using Biological Fluids , Press Release
  • March 18, 2002 - Emerging Microarray Technologies and Applications, IBC LifeSciences, March 18-19, 2002, San Diego, CA, “AntibiomixTM – High-throughput Target Validation and Large-scale Identification of Protein Functions” Invited Speaker, Dr. Moncef Jendoubi
  • March 2002 - Transcriptome 2002, The Institute for Genomic Research, March 10-13, 2002, Seattle, WA, "Breaking the bottle neck of Genomics and Proteomics," Invited Speaker, Dr. Moncef Jendoubi
  • February 23, 2002 – CHI Genome Tri-Conference: Genomic Partnering, Human Genome Discovery, Gene Functional Analysis, February 23-24, 2002, Santa Clara, CA, "Immune System Stimulation to Rapidly Generate High-Avidity Polyclonal Antibodies", Invited Speaker, Dr. Moncef Jendoubi
  • January/February 2002 (PDF file) - "Ascent of antibody," Dr. Rathin Das, American Genomic/Proteomic Technology, March 2002, pp 6-7, Milagen is featured in the editor’s page focusing on the utility of antibodies as therapeutic agents and as drug discovery tools
  • January 28, 2002 - Drug Discovery Japan, CHI, January 28-31, 2002, Tokyo, Japan, "AntibiomixTM - A Paradigm Shift in High-throughput Target Validation", Invited Speaker, Dr. Moncef Jendoubi

2001

  • August 15, 2001 –Drug Discovery Technology 2001, IBC LifeSciences, August 12-17, 2001, Boston, MA, C. Chavany, J-F. Martini, R.P.C. Valle, M. Jendoubi, "High throughput Antibody-based Target Discovery and Validation for Diagnostics and Therapeutics" Poster Presentation, Dr. Wilbur Huang
  • July 16, 2001 – Bio-Century Emerging Company Profile "Milagen: Antibodies, quick time" by Shauna Farr-Jones